Adial Pharmaceuticals- Warrants (31/07/2023) Accounts Payable

As of the most recent data (June 2026), ADILW shows a accounts payable of $2.6M. That compares with $670K in the prior-year period — up 291.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADILW's accounts payable is now $2.6M (was $670K) — a 291.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adial Pharmaceuticals- Warrants (31/07/2023) is outperforming or lagging.

Tracking ADILW's accounts payable over time shows whether Adial Pharmaceuticals- Warrants (31/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6M That compares with $670K in the prior-year period — up 291.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.6M) with ownership activity and broader fundamentals.

Adial Pharmaceuticals- Warrants (31/07/2023)'s accounts payable is $2.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.